pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
GILEAD SCIENCES INC · news · pharmadog
← back to GILEAD SCIENCES INC
News mentioning GILEAD SCIENCES INC
84
stories
Jul 23, 26
Biopharma layoffs must double in H2 for 2026 to match 2025 cuts
biospace
Jul 22, 26
Repligen strikes $1.5B BioLife buyout to bag cell therapy product pharmas rely on
biospace
Jul 22, 26
Summit counters PD-1/VEGF skeptics; Celldex drug fails skin disease study
biopharma dive
Jul 21, 26
Gilead and Merck provide HIV data; Dimension Capital announces $800M fund
endpoints
Jul 20, 26
How Kyverna rode CAR T’s autoimmune wave to the FDA’s door
biospace
Jul 16, 26
Spurred by deep cuts and M&A activity, H1 layoffs could oust 14,000+ in biopharma
biospace
Jul 14, 26
STAT+: Sales from controversial U.S. drug discount program rose to $100 billion last year
stat
Jul 13, 26
STAT+: AIDS activists slam Biden R&D deal with Gilead over HIV prevention drug patents
stat
Jul 6, 26
The race for an Ebola therapy begins
stat
Jun 18, 26
Biogen adds more immune drugs in $1B buyout of secretive startup RayThera
biopharma dive
Jun 9, 26
Merck, Gilead report mixed outcomes in key lung cancer, HIV studies
biopharma dive
Jun 9, 26
Trodelvy misses in lung cancer, but Gilead and Merck have an HIV success
endpoints
Jun 9, 26
STAT+: Pharmalittle: We’re reading about a $10.6 billion GSK deal, an AstraZeneca obesity pill, and more
stat
May 29, 26
At ASCO, Merck makes case for a ‘cornerstone’ cancer drug
biopharma dive
May 29, 26
Allogene CEO to step down; Agios drug fails key test
biopharma dive
May 29, 26
STAT+: Pharmalittle: We’re reading about Replimune drug getting third try at FDA approval, a Pfizer deal in China, and more
stat
May 28, 26
GSK, Ionis unveil data for hepatitis B drug touted as ‘functional cure’
biopharma dive
May 22, 26
FDA Approves First Treatment for Chronic Hepatitis Delta Virus (HDV) Infection
fda press
May 18, 26
Merck ADC, licensed from China, hits mark in first big global trial
biopharma dive
May 8, 26
Capivasertib/Fulvestrant Yields Numerical OS Advantage in PIK3CA/AKT1/PTEN–Altered Breast Cancer
onclive
May 8, 26
Lilly, Gilead lead pharma’s M&A boom
biopharma dive
May 6, 26
Madrigal's Rezdiffra beats estimates; Gilead cuts jobs; Banyan debuts
endpoints
Apr 28, 26
STAT+: AIDS group sues Trump administration over undisclosed agreement with Gilead
stat
Apr 22, 26
Merck adds to pharma’s AI push; Roche details MS drug results
biopharma dive
← prev
page 3 of 3
next →
